company background image
TMOF logo

Thermo Fisher Scientific WBAG:TMOF Stock Report

Last Price

€580.70

Market Cap

€208.6b

7D

5.7%

1Y

16.6%

Updated

30 Jan, 2025

Data

Company Financials +

Thermo Fisher Scientific Inc.

WBAG:TMOF Stock Report

Market Cap: €208.6b

TMOF Stock Overview

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. More details

TMOF fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance4/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Thermo Fisher Scientific Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Thermo Fisher Scientific
Historical stock prices
Current Share PriceUS$580.70
52 Week HighUS$580.70
52 Week LowUS$467.45
Beta0.77
1 Month Change15.70%
3 Month Change12.84%
1 Year Change16.63%
3 Year Change11.33%
5 Year Change91.33%
Change since IPO127.65%

Recent News & Updates

Recent updates

Shareholder Returns

TMOFAT Life SciencesAT Market
7D5.7%3.2%1.3%
1Y16.6%0.5%4.3%

Return vs Industry: TMOF exceeded the Austrian Life Sciences industry which returned 0.5% over the past year.

Return vs Market: TMOF exceeded the Austrian Market which returned 4.3% over the past year.

Price Volatility

Is TMOF's price volatile compared to industry and market?
TMOF volatility
TMOF Average Weekly Movement3.5%
Life Sciences Industry Average Movement7.8%
Market Average Movement4.0%
10% most volatile stocks in AT Market6.1%
10% least volatile stocks in AT Market2.1%

Stable Share Price: TMOF has not had significant price volatility in the past 3 months compared to the Austrian market.

Volatility Over Time: TMOF's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1956122,000Marc Casperwww.thermofisher.com

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Thermo Fisher Scientific Inc. Fundamentals Summary

How do Thermo Fisher Scientific's earnings and revenue compare to its market cap?
TMOF fundamental statistics
Market cap€208.61b
Earnings (TTM)€5.89b
Revenue (TTM)€40.67b

35.4x

P/E Ratio

5.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TMOF income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)16.04
Gross Margin40.68%
Net Profit Margin14.48%
Debt/Equity Ratio71.9%

How did TMOF perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

9%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 00:16
End of Day Share Price 2025/01/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Thermo Fisher Scientific Inc. is covered by 55 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kadambari DaptardarAccountability Research Corporation
David ToungArgus Research Company
Catherine Ramsey SchulteBaird